170 related articles for article (PubMed ID: 28942878)
1. Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
Int J Cardiol; 2017 Dec; 248():376-381. PubMed ID: 28942878
[TBL] [Abstract][Full Text] [Related]
2. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.
García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L
BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113
[TBL] [Abstract][Full Text] [Related]
3. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004
[TBL] [Abstract][Full Text] [Related]
4. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
[TBL] [Abstract][Full Text] [Related]
6. Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network.
Cea Soriano L; Gaist D; Soriano-Gabarró M; García Rodríguez LA
J Thromb Haemost; 2017 Jun; 15(6):1055-1064. PubMed ID: 28371181
[TBL] [Abstract][Full Text] [Related]
7. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.
Tsoi KK; Chan FC; Hirai HW; Sung JJ
J Gastroenterol Hepatol; 2018 Oct; 33(10):1728-1736. PubMed ID: 29665624
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
[TBL] [Abstract][Full Text] [Related]
9. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML
Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482
[TBL] [Abstract][Full Text] [Related]
11. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
[TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose aspirin on colorectal cancer prevention and gastrointestinal bleeding according to bodyweight and body mass index: Analysis of UK primary care data.
Cea Soriano L; Vora P; Soriano-Gabarró M; García Rodríguez LA
Int J Cardiol; 2019 Dec; 297():135-139. PubMed ID: 31515060
[TBL] [Abstract][Full Text] [Related]
13. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.
García-Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Bibbins-Domingo K;
Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study.
Shami JJP; Zhao J; Pathadka S; Wan EYF; Blais JE; Vora P; Soriano-Gabarró M; Cheung KS; Leung WK; Wong ICK; Chan EW
BMJ Open; 2022 Feb; 12(2):e050510. PubMed ID: 35121597
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
[TBL] [Abstract][Full Text] [Related]
18. Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study.
Troelsen FS; Farkas DK; Erichsen R; Sørensen HT
BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32719046
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
